Data to be Presented on Key Pipeline Products: MitraClip® System and Absorb™ Bioresorbable Vascular Scaffold Company's XIENCE Family of Drug Eluting Stents Continues to Lead the Market, Supported by ...

MOBILITY Trial Demonstrated Absolute Pro to be Safe and Effective in Patients with Peripheral Artery Disease in the Lower Extremities Abbott Park, Illinois — Abbott today announced that the U.S. Food ...

Abbott Laboratories announced it will acquire Cardiovascular Systems, Inc. (CSI) for $890 million Thursday morning. CSI is a medical device company based in St. Paul, Minnesota that manufactures ...

Abbott's Vascular business is telling HCPs and administrators the cold, hard truth about the patient experience with Beyond Intervention, the medtech’s multiyear global research initiative. The focus ...

Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow ...

Medtech giant Abbott is buying New Brighton-based Cardiovascular Systems Inc. for $890 million, expanding its portfolio in treating artery disease. Cardiovascular Systems (CSI) specializes in ...

Abbott Laboratories, Inc. ABT recently entered into a definitive agreement to acquire Cardiovascular Systems CSII-- a medical device company with an innovative atherectomy system. The deal will help ...

Abbott Laboratories plans to acquire medical-device company Cardiovascular Systems Inc. in a deal that will boost Abbott’s vascular disease offerings. Under the terms, Cardiovascular Systems ...

ABBOTT PARK, Ill., April 27, 2023 /PRNewswire/ -- Abbott (ABT) today announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative ...

Illinois-based medical technology giant Abbott will acquire New Brighton-based medical device company Cardiovascular Systems Inc., the companies announced Wednesday. Under the terms of the agreement, ...